Sign in

Private company

Applied Molecular Transport Inc.

American pharmaceutical preparations company, incorporated in Delaware1

In its 2023 annual report the company says: “We are a clinical-stage biopharmaceutical company leveraging our proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates. We currently have two oral biologics in clinical development. Our most advanced product candidate, AMT-101, has completed a Phase 2 clinical trial in patients with chronic pouchitis and is in Phase 2 development for patients with rheumatoid arthritis (RA).”49 It is headquartered in Wilmington, Delaware.1

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersWilmington, Delaware1
  • Incorporated inDE2
  • Business addressC/O The Corporation Trust Company, Corporation Trust Center, 1209 Orange St, Wilmington, De 198012
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income34-$127.2M in 2022+350% since 2019
-$150.0M-$100.0M-$50.0M02019: -$28.3M-$28.3M20192020: -$66.7M-$66.7M2020+136%2021: -$100.8M-$100.8M2021+51%2022: -$127.2M-$127.2M2022+26%
Net income34-$126.3M in 2022+350% since 2019
-$150.0M-$100.0M-$50.0M02019: -$28.0M-$28.0M20192020: -$66.6M-$66.6M2020+137%2021: -$100.3M-$100.3M2021+51%2022: -$126.3M-$126.3M2022+26%
Fiscal year201820192020202120222023
Research and development$24.3M3$53.9M4$71.4M4$89.8M4
Operating expenses$100.8M4$127.2M4
Operating income-$28.3M3-$66.7M4-$100.8M4-$127.2M4
Income tax$03$04$04$04
Net income-$28.0M3-$66.6M4-$100.3M4-$126.3M4
Earnings per share-$2.914-$2.674-$3.254
Earnings per share (diluted)-$2.914-$2.674-$3.254
Shares (weighted, basic)37.6M shares438.8M shares4
Shares (weighted, diluted)37.6M shares438.8M shares4

Compare Applied Molecular Transport Inc. with another company

Corporate structure

Applied Molecular Transport Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Applied Molecular Transport Inc.

  • Founders Fund V Management, LLC Filed SC 13G/A on Applied Molecular Transport Inc., latest Feb 14, 2024
  • EPIQ Capital Group, LLC Filed SC 13D/A on Applied Molecular Transport Inc., latest Jan 5, 2024
  • Tahir Ph.d. Mahmood Filed SC 13G/A on Applied Molecular Transport Inc., latest Feb 9, 2023 (2 filings since Feb 11, 2022)
  • Randall Ph.d. Mrsny Filed SC 13G/A on Applied Molecular Transport Inc., latest Feb 3, 2023 (2 filings since Feb 11, 2022)
  • Capital World Investors Filed SC 13G/A on Applied Molecular Transport Inc., latest Aug 10, 2022 (2 filings since Feb 11, 2022)
  • BlackRock Filed SC 13G on Applied Molecular Transport Inc., latest Jul 8, 2022 (2 filings since Feb 4, 2022)
  • Applied Molecular Transport Inc. Wilmington, Delaware

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Applied Molecular Transport Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$17.2M4 Dec 31, 2022$13.1M4 Dec 31, 2021+31.1%
Accumulated depreciation$9.0M4 Dec 31, 2022$6.1M4 Dec 31, 2021+47.2%
Property and equipment, net$8.2M4 Dec 31, 2022$7.0M4 Dec 31, 2021+16.9%
Finance-lease assets$584.0K4 Dec 31, 2022$652.0K4 Dec 31, 2021−10.4%
Operating-lease assets (leased space)$33.2M4 Dec 31, 2022$38.1M4 Dec 31, 2021−12.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$61.1M4 Dec 31, 2022$159.8M4 Dec 31, 2021−61.7%

Leadership

Who has led Applied Molecular Transport Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Tahir Ph.d. Mahmood2020–2023
  2. Shawn Cross2023

Chair

  1. Shawn Cross2023

President

  1. Shawn Cross2022–2023

Chief financial officer

  1. Shawn Cross2020–2022
  2. Brandon Hants2022–2023

Chief operating officer

  1. Shawn Cross2022–2023
2025
Board members and other officers (14)

Former names

  • Applied Molecular Transport LLCFeb 13, 2020 to Feb 13, 20202

Timeline

  1. Dec 27, 20238-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights25
  2. Dec 26, 20238-K Shareholder vote26
  3. Dec 15, 20238-K Other events27
  4. Nov 9, 20238-K Results of operations28
  5. Oct 25, 20238-K Other events29
  6. Sep 27, 20238-K Regulation FD disclosure30
  7. Sep 21, 20238-K Entered a material agreement; Executive or director change; Regulation FD disclosure31
  8. Aug 14, 20238-K Results of operations32
  9. Aug 14, 20238-K Listing notice or transfer33
  10. Jul 24, 20238-K Executive or director change34
  11. Jun 15, 20238-K Shareholder vote35
  12. Jun 8, 20238-K Executive or director change36
  13. Mar 27, 2023New chief executive Shawn Cross becomes CEO8
  14. Jun 4, 2020New chief executive Tahir Ph.d. Mahmood becomes CEO9

Calendar

When it reported results

  1. Nov 9, 2023Reported quarterly or annual results28
  2. Aug 14, 2023Reported quarterly or annual results32
  3. May 11, 2023Reported quarterly or annual results37
  4. Mar 9, 2023Reported quarterly or annual results38
  5. Nov 7, 2022Reported quarterly or annual results39
  6. Aug 4, 2022Reported quarterly or annual results40
  7. May 9, 2022Reported quarterly or annual results41
  8. Feb 24, 2022Reported quarterly or annual results42

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

159 filings to the SEC since October 2021: 3 annual reports, 7 quarterly reports, 34 major events, 82 insider forms, 10 large holders, 23 other. The latest 20:

  1. Feb 14, 2024SC 13G/A EDGAR
  2. Jan 9, 202415-12G EDGAR
  3. Jan 5, 2024SC 13D/A EPIQ13D1 EDGAR
  4. Jan 2, 2024EFFECT EDGAR
  5. Jan 2, 2024POSASR EDGAR
  6. Jan 2, 2024POS AM EDGAR
  7. Jan 2, 2024S-8 POS EDGAR
  8. Jan 2, 2024S-8 POS EDGAR
  9. Jan 2, 2024S-8 POS EDGAR
  10. Dec 29, 20234 EDGAR
  11. Dec 28, 20234 FORM 4 SUBMISSION EDGAR
  12. Dec 28, 20234 FORM 4 SUBMISSION EDGAR
  13. Dec 28, 20234 FORM 4 SUBMISSION EDGAR
  14. Dec 28, 20234 FORM 4 SUBMISSION EDGAR
  15. Dec 28, 20234 FORM 4 SUBMISSION EDGAR
  16. Dec 28, 20234 FORM 4 SUBMISSION EDGAR
  17. Dec 28, 20234 FORM 4 SUBMISSION EDGAR
  18. Dec 28, 20234 FORM 4 SUBMISSION EDGAR
  19. Dec 27, 20238-K EDGAR
  20. Dec 26, 20238-K EDGAR

The 159 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

55 open-market trades by officers, directors and large owners since October 2021: 12 buys and 43 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 22, 2023Mahmood Tahir Ph.D.DirectorSale286,320$0.16$45.8KForm 4
Nov 22, 2023Hants BrandonCFOSale61,494$0.16$9.8KForm 4
Nov 22, 2023Cross ShawnCEO & Chair of the BoardSale110,802$0.16$17.7KForm 4
Nov 15, 2023Hants BrandonCFOSale50,146$0.16$8.0KForm 4
Nov 15, 2023Cross ShawnCEO & Chair of the BoardSale90,447$0.16$14.5KForm 4
Oct 6, 2023Mahmood Tahir Ph.D.DirectorSale184,442$0.16$29.5KForm 4
Sep 29, 2023Hants BrandonCFOSale107,540$0.16$17.2KForm 4
Sep 29, 2023Cross ShawnCEO & Chair of the BoardSale193,960$0.16$31.0KForm 4
Sep 5, 2023Mahmood Tahir Ph.D.DirectorSale2,245$0.21$471Form 4
Sep 5, 2023Hants BrandonCFOSale718$0.21$151Form 4
Sep 5, 2023Cross ShawnCEO & Chair of the BoardSale1,253$0.21$263Form 4
Jun 2, 2023Mahmood Tahir Ph.D.DirectorSale1,992$0.24$478Form 4
Jun 2, 2023Hants BrandonCFOSale2,203$0.24$529Form 4
Jun 2, 2023Cross ShawnCEO & Chair of the BoardSale4,306$0.24$1.0KForm 4
Mar 1, 2023Rich Douglas A.Chief Technical OfficerSale482$0.50$241Form 4
Mar 1, 2023Mahmood Tahir Ph.D.DirectorSale1,802$0.50$901Form 4
Mar 1, 2023Kanwar BittooChief Medical OfficerSale539$0.50$270Form 4
Mar 1, 2023Hants BrandonCFOSale504$0.50$252Form 4
Mar 1, 2023Cross ShawnCEO & Chair of the BoardSale934$0.50$467Form 4
Dec 2, 2022Rich Douglas A.Chief Technical OfficerSale4,229$1.05$4.4KForm 4

All 55 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Applied Molecular Transport Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARApplied Molecular Transport Inc.1
  • CIK0001801777
  • Employer ID (EIN)81-44814261
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business addressC/O The Corporation Trust Company, Corporation Trust Center, 1209 Orange St, Wilmington, DE 198011
  • Phone650-392-04201
  • Shares outstanding41,336,563 as of Nov 2, 20236
  • Public float$60.3M as of Jun 30, 20224
  • On EDGAR sinceFeb 13, 20201
  • Filings254 in all: 4 (109), 8-K (43), 3 (16), 10-Q (11), SC 13G/A (10), SC 13G (7), CORRESP (6), DEFA14A (5)1
    All 36 form types

    EFFECT (4), UPLOAD (4), 10-K (3), DEF 14A (3), S-8 (3), S-8 POS (3), 424B4 (2), 424B5 (2), 425 (2), DRS (2), S-1 (2), 10-K/A (1), 15-12G (1), 25-NSE (1), 4/A (1), 8-A12B (1), CERT (1), DEFM14A (1), DRS/A (1), DRSLTR (1), POS AM (1), POSASR (1), S-1/A (1), S-1MEF (1), S-3 (1), S-3ASR (1), SC 13D (1), SC 13D/A (1)

  • Latest filingsAnnual report (10-K) Mar 9, 2023
    Quarterly report (10-Q) Nov 9, 2023
    Proxy statement (DEF 14A) Apr 28, 2023
    Latest 8-K (8-K) Dec 27, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
    SEC EDGAROther events
  28. 28
  29. 29
    SEC EDGAROther events
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49